Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02345382
Title Phase I Dose Escalation of BAY1143572 in Subjects With Acute Leukemia
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors Bayer
Indications
Therapies
Age Groups: adult
Covered Countries USA | DEU

Facility Status City State Zip Country Details
Dana-Farber Cancer Institute Boston Massachusetts 02215 United States Details
Hackensack University Medical Center Hackensack New Jersey 07601 United States Details
Columbia University Medical Center New York New York 10032 United States Details
Medical University of South Carolina Charleston South Carolina 29425 United States Details
Vanderbilt University Medical Center Nashville Tennessee 37232 United States Details
Universitätsklinikum der Johann Wolfgang Goethe Universität Frankfurt Hessen 60596 Germany Details
Medizinische Fakultät Carl Gustav Carus Dresden Sachsen 01307 Germany Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field